-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Options Corner: Viking Therapeutics Sees Financial Giants Take Bullish Stance
Options Corner: Viking Therapeutics Sees Financial Giants Take Bullish Stance
Financial giants have made a conspicuous bullish move on Viking Therapeutics. Our analysis of options history for $Viking Therapeutics (VKTX.US)$ revealed 27 unusual trades.
Delving into the details, we found 48% of traders were bullish, while 44% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $142,317, and 24 were calls, valued at $1,477,692.
Projected Price Targets
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $20.0 and $115.0 for Viking Therapeutics, spanning the last three months.
Analyzing Volume & Open Interest
In terms of liquidity and interest, the mean open interest for Viking Therapeutics options trades today is 1418.18 with a total volume of 16,148.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Viking Therapeutics's big money trades within a strike price range of $20.0 to $115.0 over the last 30 days.
Viking Therapeutics Option Activity Analysis: Last 30 Days
Biggest Options Spotted:
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
---|---|---|---|---|---|---|---|---|---|---|---|
VKTX | CALL | SWEEP | BULLISH | 06/21/24 | $6.6 | $6.5 | $6.6 | $75.00 | $209.2K | 1.5K | 601 |
VKTX | CALL | SWEEP | BEARISH | 05/17/24 | $10.0 | $8.7 | $8.7 | $65.00 | $132.2K | 2.8K | 330 |
VKTX | CALL | SWEEP | BEARISH | 09/20/24 | $6.3 | $6.1 | $6.2 | $100.00 | $124.0K | 381 | 201 |
VKTX | CALL | SWEEP | BULLISH | 06/21/24 | $6.6 | $6.5 | $6.6 | $75.00 | $110.2K | 1.5K | 117 |
VKTX | CALL | SWEEP | BEARISH | 01/17/25 | $21.3 | $19.7 | $20.12 | $70.00 | $100.9K | 742 | 0 |
About Viking Therapeutics
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Following our analysis of the options activities associated with Viking Therapeutics, we pivot to a closer look at the company's own performance.
Viking Therapeutics's Current Market Status
Currently trading with a volume of 2,266,930, the VKTX's price is up by 4.23%, now at $71.77.
RSI readings suggest the stock is currently is currently neutral between overbought and oversold.
Anticipated earnings release is in 89 days.
Professional Analyst Ratings for Viking Therapeutics
In the last month, 1 experts released ratings on this stock with an average target price of $90.0.
An analyst from HC Wainwright & Co. has revised its rating downward to Buy, adjusting the price target to $90.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
Financial giants have made a conspicuous bullish move on Viking Therapeutics. Our analysis of options history for $Viking Therapeutics (VKTX.US)$ revealed 27 unusual trades.
金融巨頭對Viking Therapeutics採取了明顯的看漲舉動。我們對期權歷史的分析 $Viking Therapeutics (VKTX.US)$ 透露了27筆不尋常的交易。
Delving into the details, we found 48% of traders were bullish, while 44% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $142,317, and 24 were calls, valued at $1,477,692.
深入研究細節,我們發現48%的交易者看漲,而44%的交易者表現出看跌傾向。在我們發現的所有交易中,有3筆是看跌期權,價值爲142,317美元,24筆是看漲期權,價值1,477,692美元。
Projected Price Targets
預計價格目標
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $20.0 and $115.0 for Viking Therapeutics, spanning the last three months.
在評估了交易量和未平倉合約之後,很明顯,主要市場走勢者將注意力集中在Viking Therapeutics在過去三個月中20.0美元至115.0美元之間的價格區間上。
Analyzing Volume & Open Interest
分析交易量和未平倉合約
In terms of liquidity and interest, the mean open interest for Viking Therapeutics options trades today is 1418.18 with a total volume of 16,148.00.
就流動性和利息而言,今天Viking Therapeutics期權交易的平均未平倉合約爲1418.18,總交易量爲16,148.00。
In the following chart, we are able to follow the development of volume and open interest of call and put options for Viking Therapeutics's big money trades within a strike price range of $20.0 to $115.0 over the last 30 days.
在下圖中,我們可以跟蹤過去30天Viking Therapeutics在20.0美元至115.0美元行使價區間內的大額資金交易的看漲期權和未平倉合約的發展情況。
Viking Therapeutics Option Activity Analysis: Last 30 Days
Viking Therapeutics 期權活動分析:過去 30 天
Biggest Options Spotted:
發現的最大選擇:
Symbol |
PUT/CALL |
Trade Type |
Sentiment |
Exp. Date |
Ask |
Bid |
Price |
Strike Price |
Total Trade Price |
Open Interest |
Volume |
---|---|---|---|---|---|---|---|---|---|---|---|
VKTX |
CALL |
SWEEP |
BULLISH |
06/21/24 |
$6.6 |
$6.5 |
$6.6 |
$75.00 |
$209.2K |
1.5K |
601 |
VKTX |
CALL |
SWEEP |
BEARISH |
05/17/24 |
$10.0 |
$8.7 |
$8.7 |
$65.00 |
$132.2K |
2.8K |
330 |
VKTX |
CALL |
SWEEP |
BEARISH |
09/20/24 |
$6.3 |
$6.1 |
$6.2 |
$100.00 |
$124.0K |
381 |
201 |
VKTX |
CALL |
SWEEP |
BULLISH |
06/21/24 |
$6.6 |
$6.5 |
$6.6 |
$75.00 |
$110.2K |
1.5K |
117 |
VKTX |
CALL |
SWEEP |
BEARISH |
01/17/25 |
$21.3 |
$19.7 |
$20.12 |
$70.00 |
$100.9K |
742 |
0 |
符號 |
看跌/看漲 |
交易類型 |
情緒 |
Exp。日期 |
問 |
出價 |
價格 |
行使價 |
總交易價格 |
未平倉合約 |
音量 |
---|---|---|---|---|---|---|---|---|---|---|---|
VKTX |
打電話 |
掃 |
看漲 |
06/21/24 |
6.6 美元 |
6.5 美元 |
6.6 美元 |
75.00 美元 |
209.2 萬美元 |
1.5K |
601 |
VKTX |
打電話 |
掃 |
粗魯的 |
05/17/24 |
10.0 美元 |
8.7 美元 |
8.7 美元 |
65.00 美元 |
132.2 萬美元 |
2.8K |
330 |
VKTX |
打電話 |
掃 |
粗魯的 |
09/20/24 |
6.3 美元 |
6.1 美元 |
6.2 美元 |
100.00 美元 |
124.0K |
381 |
201 |
VKTX |
打電話 |
掃 |
看漲 |
06/21/24 |
6.6 美元 |
6.5 美元 |
6.6 美元 |
75.00 美元 |
110.2 萬美元 |
1.5K |
117 |
VKTX |
打電話 |
掃 |
粗魯的 |
01/17/25 |
21.3 美元 |
19.7 美元 |
20.12 美元 |
70.00 美元 |
100.9 萬美元 |
742 |
0 |
About Viking Therapeutics
關於維京療法
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Viking Therapeutics Inc是一家醫療保健服務提供商。該公司專門從事以代謝和內分泌失調爲重點的生物藥品開發領域。該公司的臨床項目管道包括 VK2809、VK5211、VK0214 產品。VK2809 和 VK0214 是可口服的甲狀腺激素受體 β 的組織和受體亞型選擇性激動劑。VK5211 是一種口服的非甾體選擇性雄激素受體調節劑。
Following our analysis of the options activities associated with Viking Therapeutics, we pivot to a closer look at the company's own performance.
在分析了與Viking Therapeutics相關的期權活動之後,我們將轉向仔細研究公司自身的業績。
Viking Therapeutics's Current Market Status
Viking Therapeutics的當前市場狀況
Currently trading with a volume of 2,266,930, the VKTX's price is up by 4.23%, now at $71.77.
RSI readings suggest the stock is currently is currently neutral between overbought and oversold.
Anticipated earnings release is in 89 days.
VKTX目前的交易量爲2,266,930美元,價格上漲了4.23%,目前爲71.77美元。
RSI讀數表明,該股目前在超買和超賣之間處於中立狀態。
預計收益將在89天后發佈。
Professional Analyst Ratings for Viking Therapeutics
Viking Therapeutics的專業分析師評級
In the last month, 1 experts released ratings on this stock with an average target price of $90.0.
上個月,1位專家發佈了該股的評級,平均目標價爲90.0美元。
An analyst from HC Wainwright & Co. has revised its rating downward to Buy, adjusting the price target to $90.
HC Wainwright & Co. 的一位分析師已將其評級下調至買入,將目標股價調整爲90美元。
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
與僅交易股票相比,期權是一種風險更高的資產,但它們具有更高的獲利潛力。嚴肅的期權交易者通過每天自我教育、擴大交易規模、關注多個指標以及密切關注市場來管理這種風險。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧